Literature DB >> 26440049

Alpha-linolenic acid regulates Cox2/VEGF/MAP kinase pathway and decreases the expression of HPV oncoproteins E6/E7 through restoration of p53 and Rb expression in human cervical cancer cell lines.

Rashmi Deshpande1, Prakash Mansara1, Ruchika Kaul-Ghanekar2.   

Abstract

Cervical cancer represents the largest cause of mortality in women worldwide. In our previous report, we have shown how alpha-linolenic acid (ALA), an omega-3 fatty acid, regulated the growth of cervical cancer cells. The present study aimed to explore mechanistic details for the anticancer activity of ALA in cervical cancer cell lines, SiHa and HeLa. ALA significantly modulated the growth kinetics of the cells and reduced cell migration with concomitant decrease in the expression of VEGF, MMP-2, and MMP-9 proteins. Besides this, ALA significantly decreased the expression of phosphorylated p38, pERK1/2, c-JUN, NFκB, and COX2, proteins. Most importantly, ALA reduced the expression of HPV onco-proteins E6 and E7, resulting into restoration of expression of tumor suppressor proteins, p53 and Rb. These results suggested that ALA could be explored for its therapeutic potential in cervical cancer.

Entities:  

Keywords:  Alpha-linolenic acid; Cervical cancer; HPV oncoproteins; NF-κB

Mesh:

Substances:

Year:  2015        PMID: 26440049     DOI: 10.1007/s13277-015-4170-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  48 in total

Review 1.  Anticancer drugs aimed at E6 and E7 activity in HPV-positive cervical cancer.

Authors:  S Tan; E G E de Vries; A G J van der Zee; S de Jong
Journal:  Curr Cancer Drug Targets       Date:  2012-02       Impact factor: 3.428

2.  TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays.

Authors:  Tobias Gebäck; Martin Michael Peter Schulz; Petros Koumoutsakos; Michael Detmar
Journal:  Biotechniques       Date:  2009-04       Impact factor: 1.993

3.  Alpha linolenic acid and oleic acid additively down-regulate malignant potential and positively cross-regulate AMPK/S6 axis in OE19 and OE33 esophageal cancer cells.

Authors:  Hyun-Seuk Moon; Saime Batirel; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-07-25       Impact factor: 8.694

Review 4.  Dietary modification of inflammation with lipids.

Authors:  Philip C Calder
Journal:  Proc Nutr Soc       Date:  2002-08       Impact factor: 6.297

5.  Human papillomavirus 16 E5 up-regulates the expression of vascular endothelial growth factor through the activation of epidermal growth factor receptor, MEK/ ERK1,2 and PI3K/Akt.

Authors:  S-H Kim; Y-S Juhnn; S Kang; S-W Park; M-W Sung; Y-J Bang; Y-S Song
Journal:  Cell Mol Life Sci       Date:  2006-04       Impact factor: 9.261

6.  Activation of the ERK/MAP kinase pathway in cervical intraepithelial neoplasia is related to grade of the lesion but not to high-risk human papillomavirus, virus clearance, or prognosis in cervical cancer.

Authors:  Margherita Branca; Marco Ciotti; Donatella Santini; Luigi Di Bonito; Arrigo Benedetto; Colomba Giorgi; Pierpaolo Paba; Carterio Favalli; Silvano Costa; Alberto Agarossi; Mauro Alderisio; Kari Syrjänen
Journal:  Am J Clin Pathol       Date:  2004-12       Impact factor: 2.493

7.  Human papillomavirus type 16 E6 induces cervical cancer cell migration through the p53/microRNA-23b/urokinase-type plasminogen activator pathway.

Authors:  C L Au Yeung; T Y Tsang; P L Yau; T T Kwok
Journal:  Oncogene       Date:  2011-01-17       Impact factor: 9.867

Review 8.  p38 MAP kinase: a convergence point in cancer therapy.

Authors:  James M Olson; Andrew R Hallahan
Journal:  Trends Mol Med       Date:  2004-03       Impact factor: 11.951

9.  Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.

Authors:  Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Res       Date:  2007-04-15       Impact factor: 12.701

10.  Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.

Authors:  Marie-Eve St-Germain; Veronique Gagnon; Sophie Parent; Eric Asselin
Journal:  Mol Cancer       Date:  2004-03-11       Impact factor: 27.401

View more
  7 in total

1.  α-Linolenic and γ-linolenic acids exercise differential antitumor effects on HT-29 human colorectal cancer cells.

Authors:  María José González-Fernández; Ignacio Ortea; José Luis Guil-Guerrero
Journal:  Toxicol Res (Camb)       Date:  2020-07-27       Impact factor: 3.524

2.  Down-regulated expression of miR-99a is associated with lymph node metastasis and predicts poor outcome in stage IB cervical squamous cell carcinoma: a case-control study.

Authors:  Gongyi Zhang; Rong Zhang; Ping Bai; Shumin Li; Jing Zuo; Yuanyuan Zhang; Mei Liu; Lingying Wu
Journal:  Ann Transl Med       Date:  2022-06

3.  Metabolomic Characterization of Human Model of Liver Rejection Identifies Aberrancies Linked to Cyclooxygenase (COX) and Nitric Oxide Synthase (NOS).

Authors:  Nicholas J Skill; Campbell M Elliott; Brian Ceballos; Romil Saxena; Robert Pepin; Lisa Bettcher; Matthew Ellensberg; Daniel Raftery; Mary A Malucio; Burcin Ekser; Richard S Mangus; Chandrashekhar A Kubal
Journal:  Ann Transplant       Date:  2019-06-11       Impact factor: 1.530

4.  Treatment with flaxseed oil induces apoptosis in cultured malignant cells.

Authors:  Alison L Buckner; Carly A Buckner; Sabine Montaut; Robert M Lafrenie
Journal:  Heliyon       Date:  2019-08-09

5.  Micronutrients and Breast Cancer Progression: A Systematic Review.

Authors:  Olga Cuenca-Micó; Carmen Aceves
Journal:  Nutrients       Date:  2020-11-25       Impact factor: 5.717

6.  A novel role of FoxO3a in the migration and invasion of trophoblast cells: from metabolic remodeling to transcriptional reprogramming.

Authors:  Hao Chen; Shi-Han Wang; Chang Chen; Xin-Yang Yu; Jia-Nan Zhu; Toby Mansell; Boris Novakovic; Richard Saffery; Philip N Baker; Ting-Li Han; Hua Zhang
Journal:  Mol Med       Date:  2022-08-08       Impact factor: 6.376

7.  Inhibition of COX2 enhances the chemosensitivity of dichloroacetate in cervical cancer cells.

Authors:  Bo Li; Xinzhe Li; Haojun Xiong; Peng Zhou; Zhenhong Ni; Teng Yang; Yan Zhang; Yijun Zeng; Jintao He; Fan Yang; Nan Zhang; Yuting Wang; Yingru Zheng; Fengtian He
Journal:  Oncotarget       Date:  2017-06-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.